The RB1 gene acts like a brake on cell growth, helping cells divide in a controlled way. When it is not working properly, cells can grow out of control, which can lead to retinoblastoma, a rare eye cancer that usually starts in early childhood. In medicine, this gene is important because inherited pathogenic variants in the RB1 gene can also raise the chance of other cancers later in life, including some bone and soft tissue cancers.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the code for proteins, which do the day to day work inside cells. Others mainly help direct when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. For a deeper look at this subject, you can find more in the LearnHub.
Overview
RB1Gene function
What if the gene works
The RB1 gene helps control when cells grow and divide. Its protein acts like a brake, keeping cell growth orderly and supporting normal tissue development.
Risk
What if the gene does not work
Pathogenic variants in the RB1 gene usually cause retinoblastoma, an eye cancer in childhood, and can also raise the risk of later cancers. Milder and more severe variants can influence whether both eyes are affected and how early signs appear.
Treatment
What does that mean for your treatment
A pathogenic variant in the RB1 gene can shape treatment by leading care teams to limit external beam radiation when possible, because lifelong second cancer risk is higher. Local eye preserving treatments and chemotherapy are often preferred when they can control the cancer. Long term follow up is also planned more closely after treatment.
Conditions associated with RB1
Gene function
What if the gene works
Growth in the body needs careful timing. In everyday tissues, the RB1 gene helps cells pause, divide, or settle into a stable role at the right moment. Understanding how the RB1 gene works helps explain how tissues grow in an orderly, controlled way.
The RB1 gene helps cells wait until the right signals arrive before they start copying DNA. This keeps the steps of cell division in the proper order.
Its protein helps many cells stay in a quiet resting state when no new cells are needed. That steady pause supports normal upkeep in day to day tissue life.
Inside the cell nucleus, the RB1 protein helps keep genes that drive growth at the right activity level. This fine tuning supports orderly cell behavior.
The RB1 gene also supports the shift from a dividing cell to a more specialized cell. This helps developing tissues build stable functions as they mature.
What is a variant?
A genetic variant is a minor alteration in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change a gene’s function more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the RB1 gene affect protein function in different ways: some make the RB protein too short, unstable, or absent, while others weaken how it binds partner proteins that restrain cell growth. More severe variants often remove most or all activity, while milder variants may leave some function. In the RB1 gene, this range can be linked to earlier, more widespread retinoblastoma in some people, while variants with residual activity may be associated with later or more limited disease.
How variants are linked to conditions
Pathogenic variants in the RB1 gene cause hereditary retinoblastoma, a childhood eye cancer, and inherited RB1 gene changes linked to retinoblastoma can confirm this diagnosis. People with this hereditary form may also have a higher chance of trilateral retinoblastoma and later cancers such as osteosarcoma, soft tissue sarcoma, and melanoma. Tumor-only RB1 variants are also seen in some other cancers, but those results do not by themselves show an inherited condition.
A variant is not necessarily a diagnosis
Variants in genes are a usual feature of human biology and are widespread across the population. Most do not directly affect health and instead represent normal human variation. For many genes, having a variant associated with a condition points to a possible link, not a firm diagnosis, particularly when several genes and environmental influences also play a part. Still, in certain situations, one well-defined variant in a particular gene is enough to confirm the diagnosis.
Are there things that can increase or change my risk?
For RB1, risk is mainly shaped by whether an altered copy of the gene is inherited, often from a parent, or happens early in development. If a disease-causing RB1 change is present, the chance of developing retinoblastoma is largely set by that gene change rather than lifestyle. Regular eye checks and close follow-up are what most strongly help with early detection and preventing complications.
Inheritance of RB1 variants
When looking at how RB1 gene variants are inherited, the main pattern is autosomal dominant for RB1-related retinoblastoma. This means a parent with a disease-causing variant in one copy of the RB1 gene can pass it to a child, and each pregnancy carries a 50% chance. Some children with an RB1 gene variant are the first in the family to have it because the variant arose new (de novo) and was not inherited from either parent.
What does my RB1 result mean for my family?
For RB1, a disease-causing change can run in families in a dominant pattern, so close relatives such as children, siblings, and sometimes parents may also carry it and may want to discuss testing. Each child of someone with an RB1 change can inherit it, but some cases happen for the first time in a child rather than coming from a parent. In families with an RB1 change, relatives may still be at risk even if they have never had eye cancer themselves.
Genetic information
Genetic testing
How you find out about variants
RB1 genetic testing uses blood or saliva to look for variants in the RB1 gene. A lab reads the DNA sequence to see whether a variant may explain retinoblastoma or show if it runs in a family. Results may find a relevant variant, no relevant variant, or an uncertain finding.
When should I consider getting a genetic test?
If retinoblastoma, a rare eye cancer that usually starts in early childhood, is suspected or diagnosed, RB1 genetic testing can help confirm whether it is inherited. It is also worth considering when there is a family history of retinoblastoma, because the result can guide early eye checks for children and relatives.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they explain depends on the condition and the specific type of variant involved. How the body functions over time is also shaped by many other factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. This helps explain why the same treatment may work well for one person, seem less helpful for another, or cause more side effects in someone else. Part of the difference comes from how the body breaks down, moves, and uses a drug, and inherited gene changes are one common reason for that variation.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the way people respond to medications. It studies gene drug patterns to help explain why the same treatment can work differently from one person to another. With many medicines, genes influence how strongly a drug works or how the body handles it. This information can support more informed and more personalized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the RB1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding everyday medication choices, so general questions about medicines or side effects are best discussed with your doctor. In cancer care, RB1 changes are being studied because they may affect how some tumors respond to certain targeted treatments, and your cancer care team can explain what that means for you.
History
The RB1 gene has a landmark place in medical genetics because studies of retinoblastoma, a rare eye cancer in children, helped show how inherited cancer risk can work. In 1971, Alfred Knudson proposed the “two hit” idea after noticing that children with an inherited form developed tumors differently from those with a non inherited form. This became a turning point in cancer research and helped shape the modern concept of tumor suppressor genes, which are genes that normally help keep cell growth under control. In the 1980s, researchers linked retinoblastoma to changes on chromosome 13 and then identified the RB1 gene itself. From these first observations, research expanded steadily. The RB1 gene is now widely recognized as one of the foundational discoveries in cancer genetics.